TORCHIARO, ERICA
TORCHIARO, ERICA
ONCOLOGIA
213 Design, characterization and preclinical validation of a combinatorial CAR-based immunotherapy against colorectal cancer with HER2 amplification
2022-01-01 Cortese, Marco; Torchiaro, Erica; Leto, Simonetta; Petti, Consalvo; D'Andrea, Alice; Degree, Master; Invrea, Federica; Arena, Sabrina; Medico, Enzo
Abstract 3998: Preclinical efficacy of a synthetic Notch-based combinatorial immunotherapy against colorectal cancer with HER2 amplification
2024-01-01 Cortese, Marco; Torchiaro, Erica; D'Andrea, Alice; Petti, Consalvo; Invrea, Federica; Franco, Letizia; Donini, Chiara; Leuci, Valeria; Leto, Simonetta M.; Vurchio, Valentina; Cottino, Francesca; Isella, Claudio; Arena, Sabrina; Vigna, Elisa; Bertotti, Andrea; Trusolino, Livio; Sangiolo, Dario; Medico, Enzo
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient
2023-01-01 Torchiaro, Erica; Petti, Consalvo; Arena, Sabrina; Sassi, Francesco; Migliardi, Giorgia; Mellano, Alfredo; Porporato, Roberta; Basiricò, Marco; Gammaitoni, Loretta; Berrino, Enrico; Montone, Monica; Corti, Giorgio; Crisafulli, Giovanni; Marchio', Caterina; Bardelli, Alberto; Medico, Enzo
COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)
2021-01-01 Bianchi F.; Dama E.; Di Nicolantonio F.; Baldassarre G.; Guerriero I.; Torchiaro E.; Bruno A.; Blandino G.; Allavena P.; Chiarugi P.; Sozzi G.; D'Incalci M.; Normanno N.
Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy.
2014-01-01 Musiani, Daniele; Konda, John David; Pavan, Simona; Torchiaro, Erica; Sassi, Francesco; Noghero, Alessio; Erriquez, Jessica; Perera, Timothy; Olivero, Martina; Di Renzo, Maria Flavia
HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel
2012-01-01 Pavan S ; Musiani D ; Torchiaro E ; Migliardi G ; Olivero M; Di Renzo MF
HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor.
2014-01-01 Pavan S;Musiani D;Torchiaro E;Migliardi G;Gai M;Di Cunto F;Erriquez J;Olivero M;Di Renzo MF
Inhibition of P90RSK Sensitizes Ovarian Cancer Cells to Apoptosis
2012-01-01 Torchiaro E ; Olivero M ; Pavan S ; Di Renzo MF
Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism
2016-01-01 Torchiaro, Erica; Lorenzato, Annalisa; Olivero, Martina; Valdembri, Donatella; Gagliardi, Paolo Armando; Gai, Marta; Erriquez, Jessica; Serini, Guido; Di Renzo, Maria Flavia
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification
2024-01-01 Cortese, Marco; Torchiaro, Erica; D'Andrea, Alice; Petti, Consalvo; Invrea, Federica; Franco, Letizia; Donini, Chiara; Leuci, Valeria; Leto, Simonetta Maria; Vurchio, Valentina; Cottino, Francesca; Isella, Claudio; Arena, Sabrina; Vigna, Elisa; Bertotti, Andrea; Trusolino, Livio; Sangiolo, Dario; Medico, Enzo
The Combination of Sorafenib and Everolimus abrogates mTORC-1 and mTORC2 up-regulation in preclinical models of Osteosarcoma.
2013-01-01 Pignochino Y;Dell'aglio C;Basirico M;Capozzi F;Soster M;Marchio S;Bruno S;Gammaitoni L;Sangiolo D;Torchiaro E;D'Ambrosio L;Fagioli F;Ferrari S;Alberghini M;Picci P;Aglietta M;Grignani G
The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs
2016-01-01 Lorenzato, Annalisa; Torchiaro, Erica; Olivero, Martina; Di Renzo, Maria Flavia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 213 Design, characterization and preclinical validation of a combinatorial CAR-based immunotherapy against colorectal cancer with HER2 amplification | 2022 | Cortese, Marco; Torchiaro, Erica; Leto, Simonetta; Petti, Consalvo; D'Andrea, Alice; Degree, Master; Invrea, Federica; Arena, Sabrina; Medico, Enzo | |
| Abstract 3998: Preclinical efficacy of a synthetic Notch-based combinatorial immunotherapy against colorectal cancer with HER2 amplification | 2024 | Cortese, Marco; Torchiaro, Erica; D'Andrea, Alice; Petti, Consalvo; Invrea, Federica; Franco, Letizia; Donini, Chiara; Leuci, Valeria; Leto, Simonetta M.; Vurchio, Valentina; Cottino, Francesca; Isella, Claudio; Arena, Sabrina; Vigna, Elisa; Bertotti, Andrea; Trusolino, Livio; Sangiolo, Dario; Medico, Enzo | |
| Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient | 2023 | Torchiaro, Erica; Petti, Consalvo; Arena, Sabrina; Sassi, Francesco; Migliardi, Giorgia; Mellano, Alfredo; Porporato, Roberta; Basiricò, Marco; Gammaitoni, Loretta; Berrino, Enrico; Montone, Monica; Corti, Giorgio; Crisafulli, Giovanni; Marchio', Caterina; Bardelli, Alberto; Medico, Enzo | |
| COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC) | 2021 | Bianchi F.; Dama E.; Di Nicolantonio F.; Baldassarre G.; Guerriero I.; Torchiaro E.; Bruno A.; Blandino G.; Allavena P.; Chiarugi P.; Sozzi G.; D'Incalci M.; Normanno N. | |
| Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy. | 2014 | Musiani, Daniele; Konda, John David; Pavan, Simona; Torchiaro, Erica; Sassi, Francesco; Noghero, Alessio; Erriquez, Jessica; Perera, Timothy; Olivero, Martina; Di Renzo, Maria Flavia | |
| HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel | 2012 | Pavan S ; Musiani D ; Torchiaro E ; Migliardi G ; Olivero M; Di Renzo MF | |
| HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor. | 2014 | Pavan S;Musiani D;Torchiaro E;Migliardi G;Gai M;Di Cunto F;Erriquez J;Olivero M;Di Renzo MF | |
| Inhibition of P90RSK Sensitizes Ovarian Cancer Cells to Apoptosis | 2012 | Torchiaro E ; Olivero M ; Pavan S ; Di Renzo MF | |
| Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism | 2016 | Torchiaro, Erica; Lorenzato, Annalisa; Olivero, Martina; Valdembri, Donatella; Gagliardi, Paolo Armando; Gai, Marta; Erriquez, Jessica; Serini, Guido; Di Renzo, Maria Flavia | |
| Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification | 2024 | Cortese, Marco; Torchiaro, Erica; D'Andrea, Alice; Petti, Consalvo; Invrea, Federica; Franco, Letizia; Donini, Chiara; Leuci, Valeria; Leto, Simonetta Maria; Vurchio, Valentina; Cottino, Francesca; Isella, Claudio; Arena, Sabrina; Vigna, Elisa; Bertotti, Andrea; Trusolino, Livio; Sangiolo, Dario; Medico, Enzo | |
| The Combination of Sorafenib and Everolimus abrogates mTORC-1 and mTORC2 up-regulation in preclinical models of Osteosarcoma. | 2013 | Pignochino Y;Dell'aglio C;Basirico M;Capozzi F;Soster M;Marchio S;Bruno S;Gammaitoni L;Sangiolo D;Torchiaro E;D'Ambrosio L;Fagioli F;Ferrari S;Alberghini M;Picci P;Aglietta M;Grignani G | |
| The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs | 2016 | Lorenzato, Annalisa; Torchiaro, Erica; Olivero, Martina; Di Renzo, Maria Flavia |